Prognostic indicators for long-term disability in multiple sclerosis patients

被引:35
|
作者
Damasceno, Alfredo [1 ]
Von Glehn, Felipe [1 ]
Brandao, Carlos Otavio [1 ]
Damasceno, Benito Pereira [1 ]
Cendes, Fernando [1 ]
机构
[1] Univ Campinas UNICAMP, Dept Neurol, Campinas, SP, Brazil
基金
巴西圣保罗研究基金会;
关键词
Expanded Disability Status Scale; Long-term disability; Multiple sclerosis; Prognosis; Relapses; Risk factor; NATURAL-HISTORY; PROGRESSION; PREDICTORS;
D O I
10.1016/j.jns.2012.09.020
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Daily practice is still faced with uncertainty in predicting the long-term disability of multiple sclerosis (MS). Most information comes from northern hemisphere cohorts, but in South America this information is scarce, and race, genetic and environmental factors could play an important role in the heterogeneity observed in disease outcomes. Methods: We evaluated 197 patients attending our MS Center gathering clinical and demographic information. Outcome measures analyzed were time from first clinical symptom to EDSS of 6, 7 and 8. For survival analysis we employed Cox regression models and the Kaplan-Meier method. Results: Time to EDSS 6 was 25.83 years (95% CI 15.36-36.31), and 36.25 years (95% CI 20.72-51.78) for EDSS 7. Male sex was associated with a 4.63 and 4.69 fold increased risk to EDSS 6 and 7, respectively (p < 0.001 and p = 0.006). Motor and brainstem symptoms at onset were also associated with an 8.1 and 13.1 fold increased risk to EDSS 6, respectively (p = 0.04 and p = 0.01). The number of relapses in five and ten years of disease onset was associated with a slightly increased risk to EDSS 8 (1.28 and 1.19, respectively; p = 0.032 and p = 0.015). Conclusions: Male patients presenting with frequent relapses, especially those with motor and brainstem involvement, deserve close observation and should be cautiously monitored to early signs of treatment failure. (C) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:29 / 33
页数:5
相关论文
共 50 条
  • [41] Disability in multiple sclerosis: When synaptic long-term potentiation fails
    Weiss, Sagit
    Mori, Francesco
    Rossi, Silvia
    Centonze, Diego
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2014, 43 : 88 - 99
  • [42] Long-term disability progression of paediatric-onset multiple sclerosis
    McKay, K. A.
    Hillert, J.
    Manouchehrinia, A.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 544 - 544
  • [43] Gray matter atrophy is related to long-term disability in multiple sclerosis
    Fisniku, Leonora K.
    Chard, Declan T.
    Jackson, Jonathan S.
    Anderson, Valerie M.
    Altmann, Daniel R.
    Miszkiel, Katherine A.
    Thompson, Alan J.
    Miller, David H.
    ANNALS OF NEUROLOGY, 2008, 64 (03) : 247 - 254
  • [44] Multiparity in women with multiple sclerosis causes less long-term disability: No
    McCombe, P. A.
    Callaway, L. K.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 (11) : 1435 - 1436
  • [45] Long-term predictors of disability worsening in patients with multiple sclerosis in the phase 3 TRANSFORMS study
    Repovic, P.
    Boster, A.
    Ritter, S.
    Tomic, D.
    Meng, X.
    Meier, D. Piani
    Sprenger, T.
    Barkhof, F.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 736 - 737
  • [46] Infratentorial lesions predict long-term disability in patients with initial findings suggestive of multiple sclerosis
    Minneboo, A
    Barkhof, F
    Polman, CH
    Uitdehaag, BMJ
    Knol, DL
    Castelijns, JA
    ARCHIVES OF NEUROLOGY, 2004, 61 (02) : 217 - 221
  • [47] Long-term analysis of patients with benign multiple sclerosis: new insights about the disability course
    Mathey, Guillaume
    Pische, Guillaume
    Soudant, Marc
    Pittion-Vouyovitch, Sophie
    Guillemin, Francis
    Debouverie, Marc
    Epstein, Jonathan
    JOURNAL OF NEUROLOGY, 2021, 268 (10) : 3817 - 3825
  • [48] Long-term analysis of patients with benign multiple sclerosis: new insights about the disability course
    Guillaume Mathey
    Guillaume Pisché
    Marc Soudant
    Sophie Pittion-Vouyovitch
    Francis Guillemin
    Marc Debouverie
    Jonathan Epstein
    Journal of Neurology, 2021, 268 : 3817 - 3825
  • [49] Long-term effects of dalfampridine in patients with multiple sclerosis
    Ruck, T.
    Bittner, S.
    Simon, O. J.
    Goebel, K.
    Wiendl, H.
    Schilling, M.
    Meuth, S. G.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2014, 337 (1-2) : 18 - 24
  • [50] Optic neuritis and multiple sclerosis: Long-term prognostic considerations - In reply
    Beck, RW
    Smith, CH
    Gal, RL
    ARCHIVES OF NEUROLOGY, 2005, 62 (03) : 507 - 507